|
Safety and efficacy study of IL-10 (Tenovil TM) in the prevention of Post-ERCP Acute Pancreatitis Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified health advice, travels to or treatment by using a genuine physician. We are not physicians. Always consult your dr. on Safety and efficacy study of IL-10 (Tenovil TM) in the prevention of Post-ERCP Acute Pancreatitis conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Safety and efficacy study of IL-10 (Tenovil TM) in the prevention of Post-ERCP Acute Pancreatitis Clinical research trials and Safety and efficacy study of IL-10 (Tenovil TM) in the prevention of Post-ERCP Acute Pancreatitis health trials occur in hundreds of cities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new drugs. The propose of the studies / undertakings is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Safety and efficacy study of IL-10 (Tenovil TM) in the prevention of Post-ERCP Acute Pancreatitis. Safety and efficacy study of IL-10 (Tenovil TM) in the prevention of Post-ERCP Acute Pancreatitis Clinical Trials and other clinical trials permit volunteers to acquire medical treatment choices before they are available to the masses. Some times the test subjects obtain professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Safety and efficacy study of IL-10 (Tenovil TM) in the prevention of Post-ERCP Acute Pancreatitis clinical trial. Participants oftentimes recieve the most expert healthcare available for their Safety and efficacy study of IL-10 (Tenovil TM) in the prevention of Post-ERCP Acute Pancreatitis condition. Hazards are a reality, however, and can include extra or frequent physician visits, health risks (potentially life-endangering), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Safety and efficacy study of IL-10 (Tenovil TM) in the prevention of Post-ERCP Acute Pancreatitis Safety and efficacy study of IL-10 (Tenovil TM) in the prevention of Post-ERCP Acute Pancreatitis
Safety and efficacy study of IL-10 (Tenovil TM) in the prevention of Post-ERCP Acute Pancreatitis
For Condition: Pancreatitis,Bile Duct Diseases,Biliary Tract Diseases,Gallbladder Diseases,Pancreatic Diseases
Status: Terminated
Sponsor(s): Schering-Plough ,
Synopsis: The purpose of this study is to determine if a single dose of IL-10 compared to placebo is safe and effective in reducing the incidence of post-ERCP acute pancreatitis for subjects with increased risk.
Details:
Eligibility:
Study Type: Interventional, Prevention, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion criteria: Adults weighing up to 125 kg who are undergoing ERCP for any of the following: - Evaluate recurrent abdominal pain; - Evaluate unexplained recurrent pancreatitis; - Evaluate prior post-ERCP pancreatitis; - Treatment of pancreatic disorders; - Treatment of Common Bile Duct Stones (without jaundice) Exclusion criteria: - Active (acute) pancreatitis; - Chronic pancreatitis (moderate and severe cases); - ERCP to perform a second procedure on biliary tract; - Patients who previously had pancreatic sphincterotomy; - Known or suspected pancreatic cancer or cancer of Papilla of Vater; - Known or suspected other malignancy; - History of, or current clotting or bleeding problems; - Moderate and severe Anemia; - Low platelet counts
Total Enrollment: 948
Location and Contact Information:
Columbia Presbyterian Medical Center
New York City, New York,
United States
St. Louis University - Div. of GI/Hep.
St. Louis, Missouri,
United States
Richmond GI Research Group
Richmond, Virginia,
United States
Beth Israel North
New York City, New York,
United States
University of Colorado Hospital
Aurora, Colorado,
United States
Queens Medical Center
Nottingham, ,
United Kingdom
Gastroenterology Consultants
Milwaukee, Wisconsin,
United States
Brigham & Women's Hospital
Boston, Massachusetts,
United States
Cleveland Clinic Foundation
Cleveland, Ohio,
United States
Penn State University
Hershey, Pennsylvania,
United States
Rocky Mountain Gastroenterology Associates
Lakewood, Colorado,
United States
Digestive Disorders Associates
Annapolis, Maryland,
United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania,
United States
UZ Gasthuisberg
Leuven, ,
Belgium
Ospedale San Raffaele
Milan, ,
Italy
Maimonides Medical Center
Brooklyn, New York,
United States
University of Kentucky
Lexington, Kentucky,
United States
Digestive & Liver Disease
New York City, New York,
United States
Virginia Mason Medical Center
Seattle, Washington,
United States
Univ. of Clinic of Vienna
Vienna, ,
Austria
Gastroenterology Consultants
Milwaukee, Wisconsin,
United States
Division of Gastroenterology
St. Louis, Missouri,
United States
Hennepin County Medical Center
Minneapolis, Minnesota,
United States
Mayo Clinic El
Rochester, Minnesota,
United States
Interventional Endoscopy Services
San Francisco, California,
United States
Digestive Health Physician
Cheektowaga, New York,
United States
Hospital Erasme ULB
Bruelles, ,
Belgium
Cedars Sinai Medical Center - G.I. Department
Los Angeles, California,
United States
Division of Gastroenterology
Pittsburgh, Pennsylvania,
United States
Weill Medical College of Cornell University
New York City, New York,
United States
Oakland Gastroenterology Associates
Southfield, Michigan,
United States
University of Florida
Gainesville, Florida,
United States
University of Iowa - Dept. of Internal Medicine
Iowa City, Iowa,
United States
Duke University Medical School
Durham, North Carolina,
United States
Outpatient Pavilion
Aurora, Colorado,
United States
Policlinico Gemelli
Rome, ,
Italy
Indiana University Medical Center
Indianapolis, Indiana,
United States
Clinica Santa Maria
Santiago, ,
Chile
A.P.H. Paris, Hopital Bicetre
Bicetre, ,
France
Hospices Civils de Lyon, Hopital Edouard Herriot
Lyon, ,
France
Additional Information:
Study ID Numbers: P02580;
Study Start Date:
Record last reviewed: January 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00040131
Other Pancreatic Diseases Studies:
1. Safety and efficacy study of IL-10 (Tenovil TM) in the prevention of Post-ERCP Acute Pancreatitis
Related Studies:
Other Pancreatic Diseases Clinical Trials
Other Clinical Trials
Other Bruelles Clinical Trials
Safety and efficacy study of IL-10 (Tenovil TM) in the prevention of Post-ERCP Acute Pancreatitis
|
|
|
|
|
|
|
|